What is Interstitial Lung Disease?

The interstitium is the tissue and space around the air sacs (alveoli) in the lungs. When the interstitium becomes damaged or scarred, it impairs the lungs’ ability to deliver oxygen into the bloodstream and remove carbon dioxide. Some common symptoms of ILD include shortness of breath, dry cough, fatigue, and finger clubs. The exact cause of most ILD conditions is unknown, but some activities like smoking, certain environmental exposures, and drugs may contribute to the risk. While there is no cure for ILD, treatments aim to slow disease progression and relieve symptoms.

Causes of Interstitial Lung Disease

The two main processes that cause ILD are inflammation and fibrosis. Interstitial Lung Disease Inflammation occurs when the immune system attacks the lung tissues for unknown reasons. Certain conditions like rheumatoid arthritis, scleroderma, and drug reactions activate the immune system and cause inflammation in the lungs. Fibrosis develops when the lungs repair damage through formation of excessive scar tissue in the interstitium. Repeat injury and failed repair over time leads to lung scarring and stiffness. Some known causes of ILD that promote these processes are:

- Occupational/environmental exposures - Exposures to organic dusts, fumes, minerals like silica or coal dust, metal fumes etc. that occur in certain work settings are linked to some forms of ILD.

- Smoking - Long-term smoking greatly increases the risk of pulmonary fibrosis and other ILD. It is a leading cause of IPF.

- Genetic factors - Rare genetic mutations can cause forms of ILD through abnormal lung development or impaired healing capacity.

- Autoimmune diseases - Connective tissue diseases like scleroderma or rheumatoid arthritis impact the lungs in 5-10% patients through autoimmunity.

- Medications/drugs - Chest radiation, chemotherapy, nitrofurantoin antibiotics etc. are rarely associated with medication-induced lung injury and fibrosis.

Types of Interstitial Lung Disease

There are many distinct types or patterns of ILD based on cause, appearance on scans, affected lung regions, and pathology. Some of the major categories are:

- Idiopathic pulmonary fibrosis (IPF): The most common form of ILD in older adults. Causes scarring of the lung tissues for unknown reasons. Has poor prognosis.

- Non-specific interstitial pneumonia (NSIP): Appears as patches of inflammation and scarring in both lungs. May respond well to treatment.

- Hypersensitivity pneumonitis: Caused by repetitive inhalation of organic dusts, molds or chemicals. Linked to bird fancier’s lung, bagassosis, etc.

- Connective tissue disease-associated ILD: Develops secondary to inflammatory conditions like scleroderma or rheumatoid arthritis.

- Respiratory bronchiolitis-associated ILD: Associated with long-term smoking. Presents with lesions in bronchioles.

- Lymphocytic interstitial pneumonia (LIP): Rare type where lymphocytes infiltrate lung tissue causing scarring. Usually idiopathic but sometimes linked to collagen vascular diseases.

Diagnosis and Tests for Interstitial Lung Disease

Diagnosis of ILD relies on correlating clinical symptoms with findings from medical tests. Chest imaging like high-resolution CT (HRCT) best reveals classic patterns of abnormalities in the lung tissues. Pulmonary function tests show restrictive lung disease and reduced gas exchange ability. Bronchoscopy with lung biopsies through flexible fiberoptic tube provides lung samples to examine under a microscope for characteristic pathological features of different ILDs. Other tests done include arterial blood gases, ECG, echocardiogram to evaluate heart function, and immune markers to look for connective tissue diseases. A multidisciplinary team of specialists is often required to analyse all diagnostic aspects to precisely classify the ILD type in each case.

Treatment and Management of Interstitial Lung Disease

There is no definitive treatment for many ILD conditions and lung scarring is usually not reversible. Treatment focusses on slowing disease progression, relieving symptoms, managing complications, and utilizing supportive therapies like pulmonary rehabilitation and oxygen therapy. Commonly used drug therapies include:

- Corticosteroids like prednisone which suppress lung inflammation.

- Immunosuppressants/cytotoxic drugs such as azathioprine, mycophenolate mofetil or cyclophosphamide which dampen immune activity in autoimmune ILDs.

- Tyrosine kinase inhibitors like nintedanib that prevent growth of collagen in lungs.

- Antifibrotic drugs like pirfenidone that obstruct lung scarring.

Lung transplantation may be considered for selected IPF patients in end-stage disease. Patients are counseled about maintaining a healthy lifestyle, managing stress, getting vaccinated, and promptly treating lung infections or exacerbations. Together, a multidisciplinary treatment plan can improve quality of life and slow ILD progression in many cases.



In conclusion, interstitial lung diseases are a diverse group of lung disorders characterized by scarring and inflammation of the lung tissues. While the cause is unknown for many ILDs, some are triggered by environmental/occupational exposures, repetitive injuries or connective tissue diseases. Advanced medical tests help identify the specific type to guide therapy. Treatments aim to control inflammation, block fibrosis progression, manage impairments, and provide supportive measures. Promoting awareness of risk factors and early diagnosis holds promise to optimize management outcomes for interstitial lung disease patients.

Get more insights on This Topic- Interstitial Lung Disease